Bayesian Capital Management, LP Charles River Laboratories International, Inc. Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 17,965 shares of CRL stock, worth $2.79 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
17,965Holding current value
$2.79 Million% of portfolio
0.42%Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$958 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$791 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$339 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$281 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$281 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.91B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...